BECTON DICKINSON AND CO (1BDX.MI) Stock Price, Forecast & Analysis
Europe • Euronext Milan • BIT:1BDX • US0758871091
1BDX.MI Key Statistics, Chart & Performance
The current stock price of 1BDX.MI is 156.7 EUR.
1BDX.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1BDX.MI.
1BDX.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1BDX.MI. There are concerns on the financial health of 1BDX.MI while its profitability can be described as average.
1BDX.MI Financial Highlights
Over the last trailing twelve months 1BDX.MI reported a non-GAAP Earnings per Share(EPS) of 12.47. The EPS increased by 9.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.68% | ||
| ROA | 3.03% | ||
| ROE | 6.61% | ||
| Debt/Equity | 0.69 |
1BDX.MI Forecast & Estimates
19 analysts have analysed 1BDX.MI and the average price target is 190.9 EUR. This implies a price increase of 21.83% is expected in the next year compared to the current price of 156.7.
For the next year, analysts expect an EPS growth of 3.94% and a revenue growth 4.3% for 1BDX.MI
1BDX.MI Ownership
1BDX.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.28 | 111.57B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.75 | 108.30B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.64 | 47.55B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.73 | 23.84B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.61 | 23.68B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.46 | 23.46B | ||
| BIM.PA | BIOMERIEUX | 25.22 | 11.52B | ||
| DIA.MI | DIASORIN SPA | 22.45 | 4.16B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 130.69 | 3.93B | ||
| 1AFX.MI | CARL ZEISS MEDITEC AG - BR | 17.45 | 2.51B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 17.14 | 2.47B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 13.75 | 1.66B |
Related stock screener links
About 1BDX.MI
Company Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Company Info
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY US
Employees: 74000
Phone: 12018476800
BECTON DICKINSON AND CO / 1BDX.MI FAQ
Can you describe the business of BECTON DICKINSON AND CO?
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
What is the current price of 1BDX stock?
The current stock price of 1BDX.MI is 156.7 EUR. The price decreased by -4.89% in the last trading session.
Does 1BDX stock pay dividends?
BECTON DICKINSON AND CO (1BDX.MI) has a dividend yield of 2.37%. The yearly dividend amount is currently 3.28.
How is the ChartMill rating for BECTON DICKINSON AND CO?
1BDX.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the valuation of BECTON DICKINSON AND CO (1BDX.MI) based on its PE ratio?
The PE ratio for BECTON DICKINSON AND CO (1BDX.MI) is 12.57. This is based on the reported non-GAAP earnings per share of 12.47 and the current share price of 156.7 EUR.
How many employees does BECTON DICKINSON AND CO have?
BECTON DICKINSON AND CO (1BDX.MI) currently has 74000 employees.
What is the market capitalization of 1BDX stock?
BECTON DICKINSON AND CO (1BDX.MI) has a market capitalization of 44.91B EUR. This makes 1BDX.MI a Large Cap stock.